She also leads the Global Healthcare Sector for Deloitte and am a principal in Deloitte Consulting. For more than two decades working in Life Sciences and Healthcare, she participated in a broad range of strategic advisory services, including creating global business models, product development, regulatory affairs, mergers, marketing, product launches, and reengineering information management processes.

Prior to joining Deloitte Consulting, she worked in the pharmaceutical industry managing clinical development, regulatory affairs, sales and marketing; and I’ve gained a broad range of experience in developing new products and obtaining product licenses in the UK and the U.S. In addition to consulting work, Teri frequently participates in industry conferences, discussing inclusion in the workplace and evolving healthcare and life sciences trends, including emerging cognitive technologies that promise to transform healthcare significantly. Her perspective on these topics has appeared in the Harvard Business Review, Modern Healthcare, and other publications. She serves on the Board of City Year NY, which places highly trained young people of all backgrounds full-time in schools as tutors, mentors and role models. Additionally, she is a member of the Board of The Friends of the Patients of the NIH, which provides emotional and financial support to the incredibly brave patients receiving groundbreaking and life-saving treatments at the NIH. She holds a Joint Honors Bachelor of Science degree in chemistry/pharmacology and a PhD in pharmacology from the University of London